{
    "title": "Drug trial slows Alzheimer's progression by 35 per cent",
    "url": "https://www.dailymail.co.uk/wires/aap/article-12045537/Drug-trial-slows-Alzheimers-progression-35-cent.html",
    "date": "2023-05-04",
    "keywords": [
        "disease",
        "drug",
        "cent",
        "trial",
        "donanemab",
        "decline",
        "university",
        "cognition",
        "ability",
        "living",
        "scale",
        "musgrave",
        "collinspraino",
        "progress",
        "phase",
        "company",
        "thursday",
        "rating",
        "slowing",
        "risk",
        "stage",
        "placebo",
        "debilitating",
        "age",
        "cause",
        "death",
        "research",
        "foundation",
        "lecturer",
        "pharmacology",
        "progression",
        "removal",
        "plaque",
        "rate",
        "treatment",
        "dr",
        "professor",
        "bruce",
        "consultant",
        "physician",
        "neurologist",
        "nsw",
        "time",
        "future",
        "lyndsey",
        "head",
        "ageing",
        "laboratory",
        "school",
        "biomedicine",
        "prof",
        "promise",
        "evaluation",
        "profile",
        "safety",
        "peer",
        "review",
        "submission",
        "food",
        "administration",
        "quarter",
        "step",
        "vice",
        "president"
    ],
    "category": [
        "wires",
        "aap"
    ]
}